Gene Silencing in Cancer in Association with Promoter Hypermethylation

James G. Herman(Johns Hopkins University), Stephen B. Baylin
New England Journal of Medicine
November 19, 2003
Cited by 3,412

Abstract

This article reviews the mechanisms of gene silencing in cancer and clinical applications of this phenomenon. The silencing of genes, especially tumor-suppressor genes, is a key event in the development of cancer. The silencing can be effected by a disabling mutation or by a shutting down of the promoter region, the site at which transcription of the gene begins.


Related Papers

No related papers found

Powered by citation graph analysis